Minakem CDMO News and Resources

The Minafin Group has appointed Olivier Ubrich as CEO of its Health Chemistry division, which encompasses Minakem CDMO and Minakem Generics & New Therapies. Ubrich, who joins the Minafin Executive Committee, brings extensive international experience. He previously held leadership roles